Cargando…

Syndecan-2: Old Player in a New Field

Detalles Bibliográficos
Autores principales:	Obraztsova, Kseniya, Evans, Jilly, Krymskaya, Vera P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543750/ https://www.ncbi.nlm.nih.gov/pubmed/30896971 http://dx.doi.org/10.1165/rcmb.2019-0033ED

Ejemplares similares

CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis
por: Evans, Jilly Frances, et al.
Publicado: (2021)

Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 Inhibitor
por: Evans, Jilly F., et al.
Publicado: (2019)

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells
por: Himes, Blanca E., et al.
Publicado: (2018)

Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis
por: Evans, Jilly F., et al.
Publicado: (2023)

Metabolism and Cancer: Old and New Players
por: Cerella, Claudia, et al.
Publicado: (2013)

Syndecan-2 Methylation as a New Biomarker for Early Detection of Colorectal Neoplasm
por: Kim, Ji Hyun, et al.
Publicado: (2018)

Zonnic®: a new player in an old field
por: Gong, Min, et al.
Publicado: (2017)

Enlightening Ways to Relax Airway Smooth Muscle: Opsins
por: Krymskaya, Vera P., et al.
Publicado: (2021)

Shed syndecan-2 inhibits angiogenesis
por: De Rossi, Giulia, et al.
Publicado: (2014)

Investigating the Pea Virome in Germany—Old Friends and New Players in the Field(s)
por: Gaafar, Yahya Z. A., et al.
Publicado: (2020)

Tranexamic Acid; A Glittering Player in the Field of Trauma
por: Ghaffarpasand, Fariborz, et al.
Publicado: (2020)

mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline
por: Obraztsova, Kseniya, et al.
Publicado: (2020)

Syndecan‐4, a model proteoglycan to study endothelial glycocalyx mechanosensing and signal transduction
por: van den Berg, Bernard M.
Publicado: (2019)

The Cardiac Syndecan-2 Interactome
por: Mathiesen, Sabrina Bech, et al.
Publicado: (2020)

Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma?
por: Lee, Je-Jung
Publicado: (2010)

Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2
por: Péterfia, Bálint, et al.
Publicado: (2012)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

Cobll1: A new player in CML
por: Kim, Hongtae, et al.
Publicado: (2017)

Is Syndecan-2 a Key Angiogenic Element?
por: Noguer, Oriol, et al.
Publicado: (2009)

NEW PLAYERS FOR THE NEW ERA: WORKING TOGETHER FOR THE PROMOTION OF HEALTH
por: Al Khateeb, Mohamed
Publicado: (2006)

Cdc14b: A New Player in Aging
por: Wei, Zhubo, et al.
Publicado: (2011)

FSTL-1: A New Player in the Prevention of Emphysema
por: Vlahos, Ross
Publicado: (2020)

Inflammation in Renal Diseases: New and Old Players
por: Andrade-Oliveira, Vinicius, et al.
Publicado: (2019)

Gasdermins in Apoptosis: New players in an Old Game
por: Rogers, Corey, et al.
Publicado: (2019)

Syndecans in Inflammation at a Glance
por: Gopal, Sandeep
Publicado: (2020)

The New and the Old
Publicado: (1900)

Significance of the Syndecan-4-Transglutaminase-2 Interaction
por: Verderio, Elisabetta, et al.
Publicado: (2010)

New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome
por: Chartoumpekis, Dionysios V, et al.
Publicado: (2013)

Lipid Metabolism: A New Player in the Conundrum of Lung Fibrosis
por: Summer, Ross, et al.
Publicado: (2019)

Fetal microchimerism and beyond: a new player in regenerative medicine
por: Shangaris, Panicos, et al.
Publicado: (2023)

Substituted Syndecan-2-Derived Mimetic Peptides Show Improved Antitumor Activity over the Parent Syndecan-2-Derived Peptide
por: Jang, Bohee, et al.
Publicado: (2022)

Syndecan-1 in Liver Diseases
por: Regős, Eszter, et al.
Publicado: (2019)

Syndecan-Regulated Receptor Signaling
por: Rapraeger, Alan C.
Publicado: (2000)

Syndecan-3 gets the message
por: Leslie, Mitch
Publicado: (2011)

Syndecan-3 in Inflammation and Angiogenesis
por: Arokiasamy, Samantha, et al.
Publicado: (2020)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Autophagy and SARS-CoV-2-Old Players in New Games
por: Ivanova, Tsvetomira, et al.
Publicado: (2023)

A cytoplasmic C-terminal fragment of syndecan-1 is generated by sequential proteolysis and antagonizes syndecan-1 dependent lung tumor cell migration
por: Pasqualon, Tobias, et al.
Publicado: (2015)

Out With the Old; in With the New
por: Kalantar Motamedi, Mohammad Hosein
Publicado: (2012)

B Cells: The Old New Players in Reproductive Immunology
por: Fettke, Franziska, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ajqmkan2ssp8fc27lsm8l705h5